chlamydia: be higher in females

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents infection
Weight: 0.54
, organism
Weight: 0.33
Siblings syphilis
Weight: 0.35
, gonorrhea
Weight: 0.35
, lyme disease
Weight: 0.34
, genital herpes
Weight: 0.34

Related properties

Property Similarity
be higher in females 1.00
affect females 0.88
affect males 0.84
be active in males 0.82
be such threat to females 0.80
be diagnosed in males 0.76

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.04
Rule weight: 0.13
Evidence weight: 0.40
Similarity weight: 0.84
Evidence: 0.79
¬ Remarkable(chlamydia, be higher in females)
Evidence: 0.76
¬ Remarkable(gonorrhea, affect males)

Remarkability from sibling implausibility

0.46
Rule weight: 0.60
Evidence weight: 0.92
Similarity weight: 0.84
Evidence: 0.47
Plausible(chlamydia, be higher in females)
Evidence: 0.76
Remarkable(gonorrhea, affect males)
Evidence: 0.60
¬ Plausible(gonorrhea, affect males)

Salient implies Plausible

0.19
Rule weight: 0.28
Evidence weight: 0.67
Similarity weight: 1.00
Evidence: 0.47
Plausible(chlamydia, be higher in females)
Evidence: 0.61
¬ Salient(chlamydia, be higher in females)

Similarity expansion

0.69
Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.88
Evidence: 0.39
Typical(chlamydia, be higher in females)
Evidence: 0.13
¬ Typical(chlamydia, affect females)
0.61
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.88
Evidence: 0.47
Plausible(chlamydia, be higher in females)
Evidence: 0.35
¬ Plausible(chlamydia, affect females)
0.60
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.88
Evidence: 0.79
Remarkable(chlamydia, be higher in females)
Evidence: 0.94
¬ Remarkable(chlamydia, affect females)
0.60
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.82
Evidence: 0.79
Remarkable(chlamydia, be higher in females)
Evidence: 0.70
¬ Remarkable(chlamydia, be active in males)
0.59
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.84
Evidence: 0.79
Remarkable(chlamydia, be higher in females)
Evidence: 0.80
¬ Remarkable(chlamydia, affect males)
0.58
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.76
Evidence: 0.79
Remarkable(chlamydia, be higher in females)
Evidence: 0.47
¬ Remarkable(chlamydia, be diagnosed in males)
0.57
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.88
Evidence: 0.61
Salient(chlamydia, be higher in females)
Evidence: 0.62
¬ Salient(chlamydia, affect females)
0.57
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.80
Evidence: 0.79
Remarkable(chlamydia, be higher in females)
Evidence: 0.81
¬ Remarkable(chlamydia, be such threat to females)
0.50
Rule weight: 0.85
Evidence weight: 0.70
Similarity weight: 0.84
Evidence: 0.61
Salient(chlamydia, be higher in females)
Evidence: 0.77
¬ Salient(chlamydia, affect males)
0.49
Rule weight: 0.85
Evidence weight: 0.70
Similarity weight: 0.82
Evidence: 0.61
Salient(chlamydia, be higher in females)
Evidence: 0.77
¬ Salient(chlamydia, be active in males)
0.49
Rule weight: 0.85
Evidence weight: 0.68
Similarity weight: 0.84
Evidence: 0.47
Plausible(chlamydia, be higher in females)
Evidence: 0.60
¬ Plausible(chlamydia, affect males)
0.48
Rule weight: 0.85
Evidence weight: 0.67
Similarity weight: 0.84
Evidence: 0.39
Typical(chlamydia, be higher in females)
Evidence: 0.54
¬ Typical(chlamydia, affect males)
0.47
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.76
Evidence: 0.61
Salient(chlamydia, be higher in females)
Evidence: 0.68
¬ Salient(chlamydia, be diagnosed in males)
0.46
Rule weight: 0.85
Evidence weight: 0.68
Similarity weight: 0.80
Evidence: 0.61
Salient(chlamydia, be higher in females)
Evidence: 0.82
¬ Salient(chlamydia, be such threat to females)
0.45
Rule weight: 0.85
Evidence weight: 0.64
Similarity weight: 0.82
Evidence: 0.47
Plausible(chlamydia, be higher in females)
Evidence: 0.67
¬ Plausible(chlamydia, be active in males)
0.44
Rule weight: 0.85
Evidence weight: 0.65
Similarity weight: 0.80
Evidence: 0.47
Plausible(chlamydia, be higher in females)
Evidence: 0.66
¬ Plausible(chlamydia, be such threat to females)
0.43
Rule weight: 0.85
Evidence weight: 0.63
Similarity weight: 0.80
Evidence: 0.39
Typical(chlamydia, be higher in females)
Evidence: 0.60
¬ Typical(chlamydia, be such threat to females)
0.42
Rule weight: 0.85
Evidence weight: 0.64
Similarity weight: 0.76
Evidence: 0.47
Plausible(chlamydia, be higher in females)
Evidence: 0.67
¬ Plausible(chlamydia, be diagnosed in males)
0.41
Rule weight: 0.85
Evidence weight: 0.59
Similarity weight: 0.82
Evidence: 0.39
Typical(chlamydia, be higher in females)
Evidence: 0.67
¬ Typical(chlamydia, be active in males)
0.34
Rule weight: 0.85
Evidence weight: 0.53
Similarity weight: 0.76
Evidence: 0.39
Typical(chlamydia, be higher in females)
Evidence: 0.77
¬ Typical(chlamydia, be diagnosed in males)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.88
Similarity weight: 1.00
Evidence: 0.61
Salient(chlamydia, be higher in females)
Evidence: 0.39
¬ Typical(chlamydia, be higher in females)
Evidence: 0.79
¬ Remarkable(chlamydia, be higher in females)

Typical implies Plausible

0.38
Rule weight: 0.48
Evidence weight: 0.79
Similarity weight: 1.00
Evidence: 0.47
Plausible(chlamydia, be higher in females)
Evidence: 0.39
¬ Typical(chlamydia, be higher in females)

Typicality and Rermarkability incompatibility between siblings

0.06
Rule weight: 0.14
Evidence weight: 0.55
Similarity weight: 0.84
Evidence: 0.79
¬ Remarkable(chlamydia, be higher in females)
Evidence: 0.57
¬ Typical(gonorrhea, affect males)